Evidence map›Paper›PMID 27936185›Full record

ArticlePloS one2016

Hedgehog Signaling Overcomes an EZH2-Dependent Epigenetic Barrier to Promote Cholangiocyte Expansion.

Nidhi Jalan-Sakrikar, Thiago M De Assuncao, Jie Lu, Luciana L Almada, Gwen Lomberk, Martin E Fernandez-Zapico, Raul Urrutia, Robert C Huebert

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review: Pathogenesis of cholestatic liver diseases.World journal of hepatology · 2020
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Nidhi Jalan-SakrikarDivision of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MN, United States of America.
Thiago M De AssuncaoDivision of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MN, United States of America.
Jie LuDivision of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MN, United States of America.
Luciana L AlmadaSchultze Center for Novel Therapeutics, Mayo Clinic and Foundation, Rochester, MN, United States of America.
Gwen LomberkDivision of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MN, United States of America.
Martin E Fernandez-ZapicoSchultze Center for Novel Therapeutics, Mayo Clinic and Foundation, Rochester, MN, United States of America.
Raul UrrutiaDivision of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MN, United States of America.
Robert C HuebertDivision of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MN, United States of America.
Mayo Clinic · US

Funding

PILOT AND FEASIBILTY PROGRAMP30DK084567 · NIDDK · MAYO CLINIC ROCHESTER · PI GREGORY J. GORES · 2009 to 2026
$22.2M
ZINC FINGER GENES AND PANCREATIC CELL GROWTHR01DK052913 · NIDDK · MEDICAL COLLEGE OF WISCONSIN · PI LOMBERK, GWEN, URRUTIA, RAUL A. · 1998 to 2023
$7.0M
miRNA Regulation of Aquaporin 1 Modulates Vascular Remodelling during CirrhosisK08DK100575 · NIDDK · MAYO CLINIC ROCHESTER · PI HUEBERT, ROBERT CHRISTIAN · 2013 to 2017
$757k
NIDDK NIH HHS K08 DK100575NIDDK NIH HHS P30 DK084567NIDDK NIH HHS R01 DK052913
6 · The paper itself

Abstract

BACKGROUND &

aimsDevelopmental morphogens play an important role in coordinating the ductular reaction and portal fibrosis occurring in the setting of cholangiopathies. However, little is known about how membrane signaling events in ductular reactive cells (DRCs) are transduced into nuclear transcriptional changes to drive cholangiocyte maturation and matrix deposition. Therefore, the aim of this study was to investigate potential mechanistic links between cell signaling events and epigenetic regulators in DRCs.

methodsUsing directed differentiation of induced pluripotent stem cells (iPSC), isolated DRCs, and in vivo models, we examine the mechanisms whereby sonic hedgehog (Shh) overcomes an epigenetic barrier in biliary precursors and promotes both cholangiocyte maturation and deposition of fibronectin (FN).

resultsWe demonstrate, for the first time, that Gli1 influences the differentiation state and fibrogenic capacity of iPSC-derived hepatic progenitors and isolated DRCs. We outline a novel pathway wherein Shh-mediated Gli1 binding in key cholangiocyte gene promoters overcomes an epigenetic barrier conferred by the polycomb protein, enhancer of zeste homolog 2 (EZH2) and initiates the transcriptional program of cholangiocyte maturation. We also define previously unknown functional Gli1 binding sites in the promoters of cytokeratin (CK)7, CK19, and FN. Our in vivo results show that EZH2 KO mice fed the choline-deficient, ethanolamine supplemented (CDE) diet have an exaggerated cholangiocyte expansion associated with more robust ductular reaction and increased peri-portal fibrosis.

conclusionWe conclude that Shh/Gli1 signaling plays an integral role in cholangiocyte maturation in vitro by overcoming an EZH2-dependent epigenetic barrier and this mechanism also promotes biliary expansion in vivo.

Indexed as

Epigenesis, GeneticAnimalsEnhancer of Zeste Homolog 2 ProteinHedgehog ProteinsMiceMice, Inbred C57BLSignal TransductionEnhancer of Zeste Homolog 2 ProteinHedgehog Proteins

Identifiers

PMID27936185
PMCPMC5148157
OpenAlexW2560667448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.